| Year |
Citation |
Score |
| 2021 |
Syed YA, Jiang C, Switchenko J, Kirmani K, Kelsey C, Khan MK. Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis. Cureus. 13: e17107. PMID 34527492 DOI: 10.7759/cureus.17107 |
0.31 |
|
| 2020 |
Switchenko JM, Jennings JM, Waller LA. Exploring spatially varying demographic associations with gonorrhea incidence in Baltimore, Maryland, 2002-2005. Journal of Geographical Systems. 22: 201-216. PMID 33692652 DOI: 10.1007/S10109-020-00321-7 |
0.492 |
|
| 2020 |
Patel SA, Switchenko JM, Fischer-Valuck B, Zhang C, Rose BS, Chen RC, Jani AB, Royce TJ. Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer. Radiation Oncology (London, England). 15: 217. PMID 32933541 DOI: 10.1186/S13014-020-01658-5 |
0.314 |
|
| 2020 |
Kudelka MR, Switchenko JM, Lechowicz MJ, Esiashvili N, Flowers CR, Khan MK, Allen PB. Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy. Clinical Lymphoma, Myeloma & Leukemia. PMID 32703750 DOI: 10.1016/J.Clml.2020.06.020 |
0.342 |
|
| 2020 |
Eng NL, Mustin DE, Lovasik BP, Turgeon MK, Gamboa AC, Shah MM, Cardona K, Sarmiento JM, Russell MC, Maithel SK, Switchenko JM, Kooby DA. Relationship between Cancer Diagnosis and Complications Following Pancreatoduodenectomy for Duodenal Adenoma. Annals of Surgical Oncology. PMID 32691338 DOI: 10.1245/S10434-020-08767-1 |
0.316 |
|
| 2020 |
Allen PB, Switchenko J, Ayers A, Kim E, Lechowicz MJ. Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL). Leukemia & Lymphoma. 1-7. PMID 32558600 DOI: 10.1080/10428194.2020.1779259 |
0.352 |
|
| 2020 |
Shaib WL, Zakka K, Shahin AA, Yared F, Switchenko JM, Wu C, Akce M, Alese OB, Patel PR, Mcdonald M, El-Rayes BF. Radiation as a Single-Modality Treatment in Localized Pancreatic Cancer. Pancreas. PMID 32541638 DOI: 10.1097/Mpa.0000000000001584 |
0.353 |
|
| 2020 |
Lee MJ, Koff JL, Switchenko JM, Jhaney CI, Harkins RA, Patel SP, Dave SS, Flowers CR. Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-Cell lymphoma. Cancer. PMID 32469082 DOI: 10.1002/Cncr.32866 |
0.305 |
|
| 2020 |
Gamboa AC, Meyer BI, Switchenko JM, Rupji M, Lee RM, Turgeon MK, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma? Journal of Surgical Oncology. PMID 32462769 DOI: 10.1002/Jso.25990 |
0.304 |
|
| 2020 |
Baddour HM, Ochsner MC, Patel MR, Switchenko JM, Beitler JJ, Magliocca K, Baugnon KL, Solares CA, Steuer CE, El-Deiry MW. Surgical Resection is Justifiable for Oral T4b Squamous Cell Cancers With Masticator Space Invasion. The Laryngoscope. PMID 32460370 DOI: 10.1016/J.Ijrobp.2019.11.239 |
0.342 |
|
| 2020 |
Buchwald ZS, Tian S, Rossi M, Smith GH, Switchenko J, Hauenstein JE, Moreno CS, Press RH, Prabhu RS, Zhong J, Saxe DF, Neill SG, Olson JJ, Crocker IR, Curran WJ, et al. Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma. Scientific Reports. 10: 7355. PMID 32355162 DOI: 10.1038/S41598-020-63789-9 |
0.341 |
|
| 2020 |
Royce TJ, Switchenko JM, Zhang C, Spratt DE, Chen RC, Jani AB, Patel SA. Utilization of androgen deprivation therapy (ADT) and stereotactic body radiation therapy (SBRT) for localized prostate cancer (PC) in the United States (US). Journal of Clinical Oncology. 38: 370-370. DOI: 10.1200/Jco.2020.38.6_Suppl.370 |
0.388 |
|
| 2020 |
Patel SA, Switchenko JM, Zhang C, Rose BS, Fischer-Valuck BW, Jani AB, Chen RC, Royce TJ. Stereotactic body radiation therapy with androgen deprivation therapy for unfavorable-risk prostate cancer. Journal of Clinical Oncology. 38: 332-332. DOI: 10.1200/Jco.2020.38.6_Suppl.332 |
0.38 |
|
| 2020 |
Gamboa AC, Meyer BI, Switchenko JM, Rupji M, Lee RM, Turgeon MK, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Should adenosquamous esophageal carcinoma be treated like adenocarcinoma or squamous cell carcinoma? Journal of Clinical Oncology. 38: 323-323. DOI: 10.1200/Jco.2020.38.4_Suppl.323 |
0.358 |
|
| 2020 |
Khan MK, Nasti T, Yushak ML, Lawson DH, Switchenko JM, Wallington D, Kleber T, Kirmani K, Owonikoko TK, Ramalingam SS, Ahmed R. Interim results of prospective pilot phase II trial of concurrent anti-PD-1 and stereotactic radiosurgery (SRS) for melanoma and NSCLC patients with brain metastases (NCT02858869). Journal of Clinical Oncology. 38: e22002-e22002. DOI: 10.1200/Jco.2020.38.15_Suppl.E22002 |
0.357 |
|
| 2020 |
Karmali R, Switchenko JM, Goyal S, Bachanova V, Gerson J, Barta SK, Danilov AV, Grover NS, Epperla N, Burkart M, Sawalha Y, Ghosh N, Bond DA, Maddocks KJ, Badar T, et al. Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era. Journal of Clinical Oncology. 38: e20064-e20064. DOI: 10.1200/Jco.2020.38.15_Suppl.E20064 |
0.337 |
|
| 2020 |
Abernethy ER, Campbell GP, Hianik R, Thomson MC, Dixon MD, Switchenko JM, Pentz RD. Videos improve patient understanding of misunderstood chemotherapy terms in a rural population. Journal of Clinical Oncology. 38: 7022-7022. DOI: 10.1200/Jco.2020.38.15_Suppl.7022 |
0.302 |
|
| 2020 |
Switchenko JM, Jennings JM, Waller LA. Exploring spatially varying demographic associations with gonorrhea incidence in Baltimore, Maryland, 2002–2005 Journal of Geographical Systems. 22: 201-216. DOI: 10.1007/s10109-020-00321-7 |
0.412 |
|
| 2019 |
Lipscomb J, Switchenko JM, Flowers CR, Gillespie TW, Wortley PM, Bayakly AR, Almon L, Fernando R, Ward KC. Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of Georgia. Leukemia & Lymphoma. 1-9. PMID 31852329 DOI: 10.1080/10428194.2019.1702176 |
0.338 |
|
| 2019 |
Tian S, Switchenko JM, Fei T, Press RH, Abugideiri M, Saba NF, Owonikoko TK, Chen AY, Beitler JJ, Curran WJ, Gillespie TW, Higgins KA. Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups. Head & Neck. PMID 31845469 DOI: 10.1002/Hed.26042 |
0.352 |
|
| 2019 |
Parent EE, Sethi I, Nye J, Holder C, Olson JJ, Switchenko J, Tade F, Akin-Akintayo OO, Abiodun-Ojo OA, Akintayo A, Schuster DM. 82Rubidium chloride PET discrimination of recurrent intracranial malignancy from radiation necrosis. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 31820882 DOI: 10.23736/S1824-4785.19.03173-X |
0.345 |
|
| 2019 |
Tanenbaum DG, Buchwald ZS, Jhaveri J, Schreibmann E, Switchenko JM, Prabhu RS, Chowdhary M, Abugidieri M, Pfister NT, Eaton B, Kahn SE, Olson JJ, Shu HG, Crocker IR, Curran WJ, et al. Dosimetric Factors Related to Radiation Necrosis after Five Fraction Radiosurgery for Patients with Resected Brain Metastases. Practical Radiation Oncology. PMID 31586666 DOI: 10.1016/J.Prro.2019.09.014 |
0.338 |
|
| 2019 |
Pentz RD, Lohani M, Hayban M, Switchenko JM, Dixon MD, DeFeo RJ, Orloff GM, Jani AB, Master VA. Videos improve patient understanding of misunderstood chemotherapy terminology. Cancer. PMID 31418849 DOI: 10.1002/Cncr.32421 |
0.351 |
|
| 2019 |
Lee RM, Switchenko JM, Ho TB, Arciero CA, Bhave MA, Subhedar PD. Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORx. Annals of Surgical Oncology. PMID 31342377 DOI: 10.1245/S10434-019-07553-Y |
0.32 |
|
| 2019 |
Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, Gamboa AC, Lee RM, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Cho CS, Weber SM, Fields RC, et al. A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. Annals of Surgery. PMID 31283562 DOI: 10.1097/Sla.0000000000003461 |
0.325 |
|
| 2019 |
Goldstein JS, Switchenko JM, Behera M, Flowers CR, Koff JL. Insurance status impacts overall survival in Burkitt lymphoma. Leukemia & Lymphoma. 1-10. PMID 31274033 DOI: 10.1080/10428194.2019.1623884 |
0.423 |
|
| 2019 |
Ferris MJ, Sykes K, Switchenko JM, Kayode OA, Wolf J, Dang Q, Press RH, Curran WJ, Higgins KA. Sparing Cardiac Substructures with Optimized Volumetric Modulated Arc Therapy and Intensity-Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer. Practical Radiation Oncology. PMID 31077884 DOI: 10.1016/J.Prro.2019.04.013 |
0.34 |
|
| 2019 |
Tian S, Switchenko JM, Jhaveri J, Cassidy RJ, Ferris MJ, Press RH, Pfister NT, Patel MR, Saba NF, McDonald MW, Higgins KA, Yu DS, Curran WJ, Gillespie TW, Beitler JJ. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base. Cancer. PMID 31012957 DOI: 10.1002/Cncr.32115 |
0.351 |
|
| 2019 |
Tian S, Switchenko JM, Cassidy RJ, Escott CE, Castillo R, Patel PR, Curran WJ, Higgins KA. Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy. Translational Lung Cancer Research. 8: 15-23. PMID 30788231 DOI: 10.21037/Tlcr.2018.10.11 |
0.351 |
|
| 2019 |
Teras LR, Diver WR, Deubler EL, Krewski D, Flowers CR, Switchenko JM, Gapstur SM. Residential ambient benzene exposure in the United States and subsequent risk of hematologic malignancies. International Journal of Cancer. PMID 30737780 DOI: 10.1002/Ijc.32202 |
0.312 |
|
| 2019 |
Bean MB, Switchenko JM, Steuer CE, Patel M, El-Deiry M, Higgins KA, McDonald MW, Chen ZG, Beitler JJ, Shin DM, Gillespie TW, Saba NF. Factors associated with metastatic presentation in HPV-related squamous cell carcinoma of the head and neck (SCCHN): A National Cancer Database (NCDB) analysis. Journal of Clinical Oncology. 37: e18213-e18213. DOI: 10.1200/Jco.2019.37.15_Suppl.E18213 |
0.355 |
|
| 2019 |
Cohen JB, Switchenko JM, Shanmugasundaram K, Goyal S, Calzada O, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov A, Grover NS, Mathews S, Burkart M, et al. Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Blood. 134: 3483-3483. DOI: 10.1182/Blood-2019-128864 |
0.315 |
|
| 2019 |
Epperla N, Switchenko JM, Shanmugasundaram K, Goyal S, Calzada O, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov A, Grover NS, Mathews S, Burkart M, et al. Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Blood. 134: 3997-3997. DOI: 10.1182/Blood-2019-128632 |
0.317 |
|
| 2019 |
Bond DA, Switchenko JM, Maddocks KJ, Churnetski MC, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Sawalha Y, Hill BT, Martin P, Gordon MJ, et al. Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma Blood. 134: 753-753. DOI: 10.1182/Blood-2019-128415 |
0.304 |
|
| 2019 |
Harkins RA, Patel SP, Lee MJ, Switchenko JM, Flowers CR. A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma Blood. 134: 3416-3416. DOI: 10.1182/Blood-2019-125779 |
0.357 |
|
| 2019 |
Sudmeier L, Switchenko J, Eaton B, Shu H. RTHP-01. PENTOXIFYLLINE AND VITAMIN E FOR THE TREATMENT OF RADIATION NECROSIS AFTER STEREOTACTIC RADIOSURGERY Neuro-Oncology. 21: vi210-vi210. DOI: 10.1093/Neuonc/Noz175.874 |
0.369 |
|
| 2019 |
Chowdhary M, Dhawan R, Switchenko J, Tian S, King K, Batus M, Fidler M, Bonomi P, Sen N, Patel K, Khan M, Gaurav M. PO-0776 Neutrophil-to-lymphocyte ratio dynamics predict for survival in lung cancer treated with SBRT Radiotherapy and Oncology. 133: S400-S401. DOI: 10.1016/S0167-8140(19)31196-X |
0.309 |
|
| 2019 |
Syed Y, Jiang C, Switchenko J, Kirmani K, Kelsey C, Khan M. Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS) International Journal of Radiation Oncology*Biology*Physics. 105: S249. DOI: 10.1016/J.Ijrobp.2019.06.370 |
0.356 |
|
| 2019 |
Churnetski MC, Switchenko JM, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Maldonado E, Gordon M, Danilov AV, Grover NS, Mathews S, Burkart M, et al. Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma after Autologous Stem Cell Transplantation Biology of Blood and Marrow Transplantation. 25: S23-S24. DOI: 10.1016/J.Bbmt.2018.12.093 |
0.408 |
|
| 2019 |
Bond D, Switchenko J, Maddocks K, Churnetski M, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson J, Barta S, Hill B, Salwaha Y, Martin P, Maldonado E, et al. OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY Hematological Oncology. 37: 408-410. DOI: 10.1002/Hon.77_2631 |
0.327 |
|
| 2019 |
Hill B, Switchenko J, Martin P, Churnetski M, Sawalha Y, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson J, Barta S, Maldonado E, Gordon M, Danilov A, et al. MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR) Hematological Oncology. 37: 405-407. DOI: 10.1002/Hon.75_2631 |
0.384 |
|
| 2018 |
Beitler JJ, Switchenko JM, Dignam JJ, McDonald MW, Saba NF, Shin DM, Magliocca KR, Cassidy RJ, El-Deiry MW, Patel MR, Steuer CE, Xiao C, Hudgins PA, Aiken AH, Curran WJ, et al. Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Cancer. PMID 30548235 DOI: 10.1002/Cncr.31820 |
0.391 |
|
| 2018 |
Shaib WL, Narayan AS, Switchenko JM, Kane SR, Wu C, Akce M, Alese OB, Patel PR, Maithel SK, Sarmiento JM, Kooby DA, El-Rayes BF. Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer. Cancer. PMID 30457666 DOI: 10.1002/Cncr.31787 |
0.374 |
|
| 2018 |
Schlafstein AJ, Withers AE, Rudra S, Danelia D, Switchenko JM, Mister D, Harari S, Zhang H, Daddacha W, Ehdaivand S, Li X, Torres MA, Yu DS. CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy. International Journal of Breast Cancer. 2018: 6945129. PMID 30405916 DOI: 10.1155/2018/6945129 |
0.394 |
|
| 2018 |
Morgan TM, Zaenger D, Switchenko JM, Eaton BR, Crocker IR, Ali AN, Shu HG. Fractionated Radiotherapy is Associated with Lower Rates of Treatment-Related Edema than Stereotactic Radiosurgery in MRI-Defined Meningiomas. World Neurosurgery. PMID 30292026 DOI: 10.1016/J.Wneu.2018.09.179 |
0.344 |
|
| 2018 |
Cassidy RJ, Switchenko JM, Yushak ML, Madden N, Khan MK, Monson DK, Beitler JJ, Landry JC, Godette KD, Gillespie TW, Patel KR. The importance of surgery in scalp angiosarcomas. Surgical Oncology. PMID 30237037 DOI: 10.1016/J.Suronc.2018.07.010 |
0.311 |
|
| 2018 |
Cassidy RJ, Switchenko JM, El-Deiry MW, Belcher RH, Zhong J, Steuer CE, Saba NF, McDonald MW, Yu DS, Gillespie TW, Beitler JJ. Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. The Laryngoscope. PMID 30194768 DOI: 10.1002/Lary.27302 |
0.348 |
|
| 2018 |
Zhong J, Switchenko J, Jegadeesh NK, Cassidy RJ, Gillespie TW, Master V, Nieh P, Alemozaffar M, Kucuk O, Carthon B, Filson CP, Bilen MA, Jani AB. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation. American Journal of Clinical Oncology. PMID 29912804 DOI: 10.1097/Coc.0000000000000471 |
0.327 |
|
| 2018 |
Calzada O, Switchenko JM, Maly JJ, Blum KA, Grover N, Mathews S, Park SI, Gordon M, Danilov A, Epperla N, Fenske TS, Hamadani M, Flowers CR, Cohen JB. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Leukemia & Lymphoma. 1-9. PMID 29912594 DOI: 10.1080/10428194.2018.1455973 |
0.398 |
|
| 2018 |
Chowdhary M, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Blumenfeld PA, Marwaha G, Diaz A, Wang D, Abrams RA, Olson JJ, Shu HG, Curran WJ, Patel KR. Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 29846893 DOI: 10.1007/S11060-018-2914-5 |
0.311 |
|
| 2018 |
Jhaveri J, Chowdhary M, Zhang X, Press RH, Switchenko JM, Ferris MJ, Morgan TM, Roper J, Dhabaan A, Elder E, Eaton BR, Olson JJ, Curran WJ, Shu HG, Crocker IR, et al. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. Journal of Neurosurgery. 1-7. PMID 29676690 DOI: 10.3171/2017.9.Jns171735 |
0.357 |
|
| 2018 |
Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK. Impact of the posttransplant lymphoproliferative disorder subtype on survival. Cancer. PMID 29579330 DOI: 10.1002/Cncr.31339 |
0.312 |
|
| 2018 |
Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, et al. Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer. PMID 29579328 DOI: 10.1002/Cncr.31328 |
0.388 |
|
| 2018 |
Zhong J, Switchenko J, Behera M, Kooby D, Maithel SK, McDonald MW, Lin JY, Cassidy RJ, El-Rayes B, Landry J, Patel PR. Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer. Annals of Surgical Oncology. PMID 29327180 DOI: 10.1245/S10434-017-6322-4 |
0.391 |
|
| 2018 |
Cassidy RJ, Zhang X, Switchenko JM, Patel PR, Shelton JW, Tian S, Nanda RH, Steuer CE, Pillai RN, Owonikoko TK, Ramalingam SS, Fernandez FG, Force SD, Gillespie TW, Curran WJ, et al. Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer. PMID 29315497 DOI: 10.1002/Cncr.31077 |
0.356 |
|
| 2018 |
Danish H, Ferris MJ, Balagamwala E, Switchenko JM, Patel KR, Choudhary M, Craven C, Mendoza P, Suh J, Bergstrom C, Grossniklaus HE, Aaberg TM, Singh A, Crocker IR, Khan MK. Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma. Melanoma Research. PMID 29303890 DOI: 10.1097/Cmr.0000000000000420 |
0.325 |
|
| 2018 |
Xu KM, Switchenko JM, Tian S, Escott CE, Pfister NT, Gillespie TW, Curran WJ, Khan MK. More effective systemic therapies are needed for chondrosarcoma: A National Cancer Data Base (NCDB) analysis. Journal of Clinical Oncology. 36: e23508-e23508. DOI: 10.1200/Jco.2018.36.15_Suppl.E23508 |
0.339 |
|
| 2018 |
Subramanian K, Switchenko JM, Flowers C, Khan MK. A meta-analysis on ABVD administration in HIV+ patients with advanced stage Hodgkin’s lymphoma (HL). Journal of Clinical Oncology. 36: e19522-e19522. DOI: 10.1200/Jco.2018.36.15_Suppl.E19522 |
0.302 |
|
| 2018 |
Ip A, Switchenko JM, Graiser M, Koff JL, Gupta VA, Lechowicz MJ, Nooka AK, Kaufman JL, Lonial S, Waller EK, Langston AA, Al-Kadhimi ZS, Kota V, Blum WG, Klisovic RB, et al. Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL). Journal of Clinical Oncology. 36: e19509-e19509. DOI: 10.1200/Jco.2018.36.15_Suppl.E19509 |
0.341 |
|
| 2018 |
Tian S, Switchenko JM, Jhaveri J, Cassidy RJ, Ferris MJ, Press RH, Pfister NT, Patel M, Saba NF, McDonald MW, Higgins KA, Yu DS, Curran WJ, Gillespie TW, Beitler JJ. Survival outcomes by HPV status in non-oropharyngeal head and neck cancers: A propensity score matched analysis of population level data. Journal of Clinical Oncology. 36: 6005-6005. DOI: 10.1200/Jco.2018.36.15_Suppl.6005 |
0.306 |
|
| 2018 |
Shaib WL, Naranyan AS, Switchenko JM, Akce M, Sarmiento J, Maithel S, Kooby DA, Patel PR, Cardona K, Alese OB, El-Rayes BF. Adjuvant treatment for resected sub-centimeter T1 pancreatic cancer. Journal of Clinical Oncology. 36: 4125-4125. DOI: 10.1200/Jco.2018.36.15_Suppl.4125 |
0.328 |
|
| 2018 |
Pentz RD, McDaniels B, Bellcross C, Shaib WL, Switchenko JM, Dixon MD. The impact of genetic counseling on patients' knowledge about tumor genomic profiling. Journal of Clinical Oncology. 36: 1592-1592. DOI: 10.1200/Jco.2018.36.15_Suppl.1592 |
0.303 |
|
| 2018 |
Shanmugasundaram K, Goyal S, Switchenko JM, Calzada O, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Barta SK, Gordon MJ, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, et al. Intensive Induction Regimens after Deferring Initial Therapy Are Not Associated with Improved Progression-Free or Overall Survival in Patients with Mantle Cell Lymphoma (MCL) Blood. 132: 4153-4153. DOI: 10.1182/Blood-2018-99-117547 |
0.336 |
|
| 2018 |
Calzada O, Bradley K, Switchenko JM, Flowers CR, Lechowicz MJ, Koff JL, Gianani R, Chandler C, Mason E, Cohen JB. Utilization of a Novel Method of Detection of CD30 Expression in Diffuse Large B-Cell Lymphoma Blood. 132: 2978-2978. DOI: 10.1182/Blood-2018-99-116986 |
0.31 |
|
| 2018 |
Ferris M, Sykes K, Kayode O, Wolf J, Press R, Switchenko J, Curran W, Higgins K. MA05.05 Photon-Based Cardiac Sparing Via Volumetric Modulated Arc Therapy in Thoracic Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 13: S371-S372. DOI: 10.1016/J.Jtho.2018.08.352 |
0.333 |
|
| 2018 |
Ip A, Switchenko JM, Graiser M, Koff J, Gupta V, Lechowicz M, Al-Kadhimi Z, Nooka A, Kaufman J, Lonial S, Waller EK, Langston AA, Flowers C, Cohen JB. Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT) Biology of Blood and Marrow Transplantation. 24: S137-S138. DOI: 10.1016/J.Bbmt.2017.12.085 |
0.3 |
|
| 2017 |
Chowdhary M, Okwan-Duodu D, Switchenko JM, Press RH, Jhaveri J, Buchwald ZS, Zhong J, Chapman BV, Bindra RS, Contessa JN, Park HS, Yu JB, Decker RH, Olson JJ, Oyesiku NM, et al. Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. Journal of Neuro-Oncology. PMID 29124649 DOI: 10.1007/S11060-017-2652-0 |
0.406 |
|
| 2017 |
Ferris MJ, Zhong J, Switchenko JM, Higgins KA, Cassidy RJ, McDonald MW, Eaton BR, Patel KR, Steuer CE, Baddour HM, Miller AH, Bruner DW, Xiao C, Beitler JJ. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28826628 DOI: 10.1016/J.Radonc.2017.08.008 |
0.374 |
|
| 2017 |
Guidot DM, Switchenko JM, Nastoupil LJ, Koff JL, Blum KA, Maly J, Flowers CR, Cohen JB. Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility. Leukemia & Lymphoma. 1-8. PMID 28797213 DOI: 10.1080/10428194.2017.1361032 |
0.342 |
|
| 2017 |
Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK. Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia. Leukemia & Lymphoma. 1-7. PMID 28782395 DOI: 10.1080/10428194.2017.1361027 |
0.369 |
|
| 2017 |
Cassidy RJ, Switchenko JM, Cheng E, Jiang R, Jhaveri J, Patel KR, Tanenbaum DG, Russell MC, Steuer CE, Gillespie TW, McDonald MW, Landry JC. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer. Cancer. PMID 28759121 DOI: 10.1002/Cncr.30896 |
0.349 |
|
| 2017 |
Cassidy RJ, Patel PR, Zhang X, Press RH, Switchenko J, Pillai R, Owonikoko TK, Ramalingam S, Fernandez F, Force S, Curran WJ, Higgins KA. Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis. International Journal of Radiation Oncology, Biology, Physics. 98: 229-230. PMID 28586990 DOI: 10.1016/J.Ijrobp.2017.01.144 |
0.372 |
|
| 2017 |
Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Cancer. PMID 28493288 DOI: 10.1002/Cncr.30706 |
0.369 |
|
| 2017 |
Cassidy RJ, Patel PR, Zhang X, Press RH, Switchenko JM, Pillai RN, Owonikoko TK, Ramalingam SS, Fernandez FG, Force SD, Curran WJ, Higgins KA. Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis. Clinical Lung Cancer. PMID 28373068 DOI: 10.1016/J.Cllc.2017.03.006 |
0.372 |
|
| 2017 |
Ferris MJ, Danish H, Switchenko JM, Deng C, George BA, Goldsmith KC, Wasilewski KJ, Cash WT, Khan MK, Eaton BR, Esiashvili N. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement. International Journal of Radiation Oncology, Biology, Physics. 97: 806-812. PMID 28244417 DOI: 10.1016/J.Ijrobp.2016.11.043 |
0.373 |
|
| 2017 |
Cassidy RJ, Switchenko JM, Jegadeesh N, Sayan M, Ferris MJ, Eaton BR, Higgins KA, Wadsworth JT, Magliocca KR, Saba NF, Beitler JJ. Association of Lymphovascular Space Invasion With Locoregional Failure and Survival in Patients With Node-Negative Oral Tongue Cancers. Jama Otolaryngology-- Head & Neck Surgery. PMID 28097311 DOI: 10.1001/Jamaoto.2016.3795 |
0.373 |
|
| 2017 |
Cassidy RJ, Cheng E, Switchenko JM, Jiang R, Jhaveri J, Tanenbaum DG, Gillespie TW, McDonald MW, Landry JC. Nationwide incidence, treatment, and outcomes of patients 80 years and older with rectal adenocarcinomas: Analysis of 5,076 patients. Journal of Clinical Oncology. 35: 723-723. DOI: 10.1200/Jco.2017.35.4_Suppl.723 |
0.397 |
|
| 2017 |
Zhong J, Patel KR, Switchenko JM, Gillespie TW, Cassidy RJ, Kooby DA, Landry JC. Comparison of outcomes in patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy (SBRT) versus conventionally fractionated radiation: An analysis of the National Cancer Database. Journal of Clinical Oncology. 35: 366-366. DOI: 10.1200/Jco.2017.35.4_Suppl.366 |
0.439 |
|
| 2017 |
Pentz RD, Pocock RH, Pinheiro AM, Switchenko JM, Dixon MD. Physician communication and patient understanding of molecular testing of tumors. Journal of Clinical Oncology. 35: e18217-e18217. DOI: 10.1200/Jco.2017.35.15_Suppl.E18217 |
0.311 |
|
| 2017 |
Steuer CE, Switchenko JM, Griffith CC, Patel M, Cassidy RJ, Gillespie TW, McDonald MW, Higgins KA, Beitler JJ, Owonikoko TK, Chen ZG, Shin DM, Saba NF. Institutional treatment volume and outcomes in salivary gland cancer. Journal of Clinical Oncology. 35: 6082-6082. DOI: 10.1200/Jco.2017.35.15_Suppl.6082 |
0.385 |
|
| 2017 |
Zhong J, Switchenko JM, Behera M, Kooby DA, McDonald MW, El-Rayes BF, Landry JC, Patel PR. Chemotherapy with or without definitive radiation therapy in locally advanced pancreatic cancer. Journal of Clinical Oncology. 35: 4103-4103. DOI: 10.1200/Jco.2017.35.15_Suppl.4103 |
0.437 |
|
| 2017 |
Goldstein JS, Switchenko JM, Behera M, Flowers C, Koff JL. Insurance Status Impacts Survival in Burkitt Lymphoma Blood. 130: 916-916. DOI: 10.1182/Blood.V130.Suppl_1.916.916 |
0.415 |
|
| 2017 |
Caulfield S, Schlafer D, Switchenko JM, Greenwell IB, Staton AD, Blum KA, Grover N, Park SI, Danilov A, Epperla N, Fenske TS, Hamadani M, Gordon MJ, Mathews S, Valla K, et al. Initial Salvage Approaches for Relapsed/Refractory Mantle Cell Lymphoma Have Comparable Response Rates, Progression-Free and Overall Survival Blood. 130: 1505-1505. DOI: 10.1182/Blood.V130.Suppl_1.1505.1505 |
0.357 |
|
| 2017 |
Russell MC, Switchenko J, Hawk NN, Gillespie TW, Chawla S. Presentation, Treatment and Survival of Younger Patients with Gastric Adenocarcinoma: A National Cancer Data Base (NCDB) Study Gastroenterology. 152: S1289. DOI: 10.1016/S0016-5085(17)34301-9 |
0.34 |
|
| 2017 |
Ferris M, Tian S, Switchenko J, Eaton B, Esiashvili N. Musculoskeletal Outcomes and the Effect of Radiation to the Vertebral Bodies on Growth Trajectories for Long-Term Survivors of High-Risk Neuroblastoma International Journal of Radiation Oncology*Biology*Physics. 99: E567. DOI: 10.1007/S13566-018-0349-4 |
0.318 |
|
| 2016 |
Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Dixon MD, Langston AA, Nooka AK, Flowers CR, Pentz RD, Waller EK. Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital. Journal of Stem Cell Research & Therapy. 6. PMID 28966870 DOI: 10.4172/2157-7633.1000328 |
0.352 |
|
| 2016 |
Sayan M, Cassidy RJ, Switchenko JM, Kayode OA, Saba NF, Steuer CE, Shin DM, Wadsworth JT, El-Deiry M, Patel M, Beitler JJ, Higgins KA. Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy. Frontiers in Oncology. 6: 272. PMID 28123995 DOI: 10.3389/Fonc.2016.00272 |
0.397 |
|
| 2016 |
Schreibmann E, Iwinski Sutter A, Whitaker D, Switchenko J, Elder E, Higgins K, Patel P. SU-F-R-07: Radiomics of CT Features and Associations and Correlation with Outcomes Following Lung SBRT. Medical Physics. 43: 3374. PMID 28047061 DOI: 10.1118/1.4955779 |
0.341 |
|
| 2016 |
Bulka C, Nastoupil LJ, Koff JL, Bernal-Mizrachi L, Ward KC, Williams JN, Bayakly AR, Switchenko JM, Waller LA, Flowers CR. Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence. Southern Medical Journal. 109: 606-614. PMID 27706495 DOI: 10.14423/SMJ.0000000000000545 |
0.441 |
|
| 2016 |
Ferris MJ, Danish H, Switchenko J, Deng C, Esiashvili N. Excellent Local Control for Consolidative Radiation Therapy Without Dose Escalation in High-Risk Neuroblastoma. International Journal of Radiation Oncology, Biology, Physics. 96: S228-S229. PMID 27675849 DOI: 10.1016/J.Ijrobp.2016.06.568 |
0.308 |
|
| 2016 |
Colbert LE, Dharmarajan KV, Switchenko J, Taniguchi CM, Hall WA, Gillespie TW, Kooby DA, Lipscomb J, Landry JC. Radiation for Pancreatic Adenocarcinoma: An End-of-Life Treatment? Assessing Appropriate Radiation Therapy Utilization in the National Cancer Data Base (NCDB). International Journal of Radiation Oncology, Biology, Physics. 96: S195. PMID 27675761 DOI: 10.1016/J.Ijrobp.2016.06.486 |
0.337 |
|
| 2016 |
Patel PR, Schreibmann E, Sutter AI, Whitaker D, Switchenko J, Curran WJ, Higgins KA. Computed Tomographic Texture Associations With Histology and Outcomes Following Lung Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E475. PMID 27674790 DOI: 10.1016/J.Ijrobp.2016.06.1822 |
0.314 |
|
| 2016 |
Abugideiri M, Patel K, Switchenko JM, Magliocca K, Buchwald ZS, Delgaudio J, Lawson DH, Danish H, Beitler JJ, Khan MK. Adjuvant Radiation Therapy Improved Local Control for Primary Mucosal Melanoma of the Head and Neck. International Journal of Radiation Oncology, Biology, Physics. 96: E384-E385. PMID 27674546 DOI: 10.1016/J.Ijrobp.2016.06.1597 |
0.321 |
|
| 2016 |
Ferris MJ, Zhong J, Switchenko J, Higgins KA, McDonald MW, Eaton BR, Miller AH, Bruner DW, Xiao C, Beitler JJ. CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E357. PMID 27674471 DOI: 10.1016/J.Ijrobp.2016.06.1529 |
0.37 |
|
| 2016 |
Danish HH, Patel KR, Switchenko JM, Gillespie TW, Jhaveri J, Chowdhary M, Abugideiri M, Delman KA, Lawson DH, Khan MK. The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis. Melanoma Research. PMID 27575390 DOI: 10.1097/Cmr.0000000000000292 |
0.371 |
|
| 2016 |
Patel KR, Chowdhary M, Switchenko JM, Kudchadkar R, Lawson DH, Cassidy RJ, Prabhu RS, Khan MK. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Research. PMID 27223498 DOI: 10.1097/Cmr.0000000000000268 |
0.406 |
|
| 2016 |
Switchenko JM, Bulka C, Ward K, Koff JL, Bayakly AR, Ryan PB, Waller LA, Flowers CR. Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiology. PMID 26949112 DOI: 10.1016/J.Canep.2016.01.008 |
0.509 |
|
| 2016 |
Ganju RG, Nanda RH, Esiashvili N, Switchenko JM, Wasilewski-Masker K, Marchak JG. The Effect of Transition Clinics on Knowledge of Diagnosis and Perception of Risk in Young Adult Survivors of Childhood Cancer. Journal of Pediatric Hematology/Oncology. PMID 26925717 DOI: 10.1097/Mph.0000000000000531 |
0.331 |
|
| 2016 |
Cassidy RJ, Jegadeesh N, Switchenko J, Danish H, Esiashvili N, Flowers CR, Khan MK. The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era. Leukemia & Lymphoma. 1-7. PMID 26759182 DOI: 10.3109/10428194.2015.1120866 |
0.401 |
|
| 2016 |
Calzada O, Switchenko JM, Maly JJ, Blum KA, Grover NS, Mathews S, Park SI, Gordon MJ, Danilov AV, Flowers C, Cohen JB. Deferred treatment as a viable option for selected patients with mantle cell lymphoma. Journal of Clinical Oncology. 34: 7567-7567. DOI: 10.1200/Jco.2016.34.15_Suppl.7567 |
0.389 |
|
| 2016 |
Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Maly JJ, Blum KA, Grover NS, Mathews S, Park SI, Gordon MJ, Danilov AV, Flowers C, Cohen JB. Association of complex karyotype with inferior progression-free and overall survival in mantle cell lymphoma. Journal of Clinical Oncology. 34: 7565-7565. DOI: 10.1200/Jco.2016.34.15_Suppl.7565 |
0.347 |
|
| 2016 |
Kettle AG, Switchenko J, Calzada O, Phan AT, Farone M, Graiser M, Flowers CR, Cohen JB. Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant Blood. 128: 5825-5825. DOI: 10.1182/Blood.V128.22.5825.5825 |
0.427 |
|
| 2016 |
Guidot DM, Sethi I, Switchenko J, Lee D, Nastoupil LJ, Koff JL, Flowers C, Cohen JB. Use of Metabolic Tumor Volume (MTV) in Patients with Mantle Cell Lymphoma Blood. 128: 5321-5321. DOI: 10.1182/Blood.V128.22.5321.5321 |
0.339 |
|
| 2016 |
Calzada O, Bradley KT, Switchenko J, Staton AD, Koff JL, Flowers CR, Cohen JB. CD30 Expression Is Not Acquired at Time of Relapse in Diffuse Large B-Cell Lymphoma Blood. 128: 4225-4225. DOI: 10.1182/Blood.V128.22.4225.4225 |
0.305 |
|
| 2016 |
Guidot DM, Switchenko J, Nastoupil LJ, Koff JL, Flowers C, Cohen JB. An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission Blood. 128: 1799-1799. DOI: 10.1182/Blood.V128.22.1799.1799 |
0.371 |
|
| 2016 |
Staton AD, Greenwell IB, Switchenko JM, Maly J, Blum K, Grover NS, Mathews S, Park SI, Gordon MJ, Danilov AV, Epperla N, Fenkse TS, Hamadani M, Flowers C, Cohen JB. Risk Stratification of Untreated Mantle Cell Lymphoma Patients Using MIPI, Ki67 Proliferative Index and Cytogenetics Blood. 128: 1785-1785. DOI: 10.1182/Blood.V128.22.1785.1785 |
0.367 |
|
| 2016 |
Staton A, Greenwell I, Switchenko J, Maly J, Blum K, Parks S, Danilov A, Flowers C, Cohen J. Discordance Between the Prognostic Impact of MIPI and Overall Survival in a Multicenter Cohort of Patients with Mantle Cell Lymphoma Clinical Lymphoma Myeloma and Leukemia. 16: S115. DOI: 10.1016/J.Clml.2016.07.166 |
0.372 |
|
| 2015 |
Oliver DE, Patel KR, Switchenko J, Parker D, Lawson DH, Delman KA, Kudchadkar RR, Khan MK. Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Research. PMID 26397051 DOI: 10.1097/Cmr.0000000000000201 |
0.412 |
|
| 2015 |
Kandula S, Switchenko JM, Harari S, Fasola C, Mister D, Yu DS, Zelnak AB, Torres MA. Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy. International Journal of Breast Cancer. 2015: 147476. PMID 26266050 DOI: 10.1155/2015/147476 |
0.364 |
|
| 2015 |
Cohen JB, Switchenko JM, Koff JL, Sinha R, Kaufman JL, Khoury HJ, Bumpers N, Colbert A, Hutchison-Rzepka A, Nastoupil LJ, Heffner LT, Langston AA, Lechowicz MJ, Lonial S, Flowers CR. A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma. British Journal of Haematology. PMID 26248505 DOI: 10.1111/Bjh.13637 |
0.356 |
|
| 2015 |
Rudra S, Yu DS, Yu ES, Switchenko JM, Mister D, Torres MA. Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer. International Journal of Breast Cancer. 2015: 213123. PMID 25949828 DOI: 10.1155/2015/213123 |
0.383 |
|
| 2015 |
Hanasoge S, Magliocca KR, Switchenko JM, Saba NF, Wadsworth JT, El-Deiry MW, Shin DM, Khuri F, Beitler JJ, Higgins KA. Clinical Outcomes in Elderly Patients with Human Papilloma Virus Positive Squamous Cell Carcinoma of the Oropharynx Treated with Definitive Chemoradiation Therapy. Head & Neck. PMID 25899391 DOI: 10.1002/Hed.24073 |
0.384 |
|
| 2015 |
Davis CC, Cohen JB, Shah KS, Hutcherson DA, Surati MJ, Valla K, Panjic EH, Handler CE, Switchenko JM, Flowers CR. Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma. Clinical Lymphoma, Myeloma & Leukemia. 15: 270-7. PMID 25704479 DOI: 10.1016/J.Clml.2014.12.011 |
0.382 |
|
| 2015 |
Heumann TR, Esiashvili N, Parker S, Switchenko JM, Dhabbaan A, Goodman M, Lechowicz MJ, Flowers CR, Khan MK. Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. International Journal of Radiation Oncology, Biology, Physics. 92: 183-91. PMID 25670538 DOI: 10.1016/J.Ijrobp.2014.11.033 |
0.332 |
|
| 2015 |
Jegadeesh NK, Kim S, Prabhu RS, Oprea GM, Yu DS, Godette KG, Zelnak AB, Mister D, Switchenko JM, Torres MA. The 21-gene recurrence score and locoregional recurrence in breast cancer patients. Annals of Surgical Oncology. 22: 1088-94. PMID 25472643 DOI: 10.1245/S10434-014-4252-Y |
0.326 |
|
| 2015 |
Kandula S, Prabhu RS, Nanda R, Switchenko JM, Cash T, Qayed M, Katzenstein H, Esiashvili N. Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma. Journal of Pediatric Hematology/Oncology. 37: 175-80. PMID 25238225 DOI: 10.1097/Mph.0000000000000264 |
0.435 |
|
| 2015 |
Lee MJ, Switchenko J, Thomas JS, Koff JL, Nastoupil L, Lechowicz MJ, Langston AA, Flowers C, Cohen JB. Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant Blood. 126: 5095-5095. DOI: 10.1182/Blood.V126.23.5095.5095 |
0.319 |
|
| 2015 |
Morgan T, Crocker I, Switchenko J, Ali A, Shu H. Radiation Therapy for MRI Defined Meningiomas: Long-term Outcomes From a Single-Institution International Journal of Radiation Oncology*Biology*Physics. 93: E97. DOI: 10.1016/J.Ijrobp.2015.07.794 |
0.404 |
|
| 2015 |
Oliver D, Patel K, Switchenko J, Parker D, Lawson D, Delman K, Kudchadkar R, Khan M. Roles of Adjuvant and Salvage Radiation Therapy for Desmoplastic Melanoma International Journal of Radiation Oncology*Biology*Physics. 93: E629. DOI: 10.1016/J.Ijrobp.2015.07.2152 |
0.317 |
|
| 2014 |
Mikell JL, Waller EK, Switchenko JM, Rangaraju S, Ali Z, Graiser M, Hall WA, Langston AA, Esiashvili N, Khoury HJ, Khan MK. Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia. International Journal of Radiation Oncology, Biology, Physics. 89: 360-9. PMID 24837891 DOI: 10.1016/J.Ijrobp.2014.02.032 |
0.329 |
|
| 2014 |
Hall WA, Colbert LE, Nickleach D, Switchenko J, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC. The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. Journal of Gastrointestinal Oncology. 5: 77-85. PMID 24772334 DOI: 10.1016/J.Ijrobp.2013.06.803 |
0.364 |
|
| 2014 |
Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC. Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Cancer. 120: 499-506. PMID 24390739 DOI: 10.1002/Cncr.28530 |
0.425 |
|
| 2014 |
Eaton BR, Losken A, Okwan-Duodu D, Schuster DM, Switchenko JM, Mister D, Godette K, Torres MA. Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy. Annals of Surgical Oncology. 21: 93-9. PMID 24081796 DOI: 10.1245/S10434-013-3235-8 |
0.322 |
|
| 2014 |
Hall WA, Nickleach D, Switchenko JM, Lipscomb J, Goodman M, Ward KC, Gillespie TW. The management of adenocarcinoma of the prostate in rural Georgia: A population-based analysis. Journal of Clinical Oncology. 32: 273-273. DOI: 10.1200/Jco.2014.32.4_Suppl.273 |
0.399 |
|
| 2014 |
Pentz RD, White TE, Dossul T, Hendershot KA, Dixon M, Salvador C, Switchenko JM, Harvey D. Development of a patient preference assessment tool for cancer patients considering phase I research. Journal of Clinical Oncology. 32: e17593-e17593. DOI: 10.1200/Jco.2014.32.15_Suppl.E17593 |
0.328 |
|
| 2014 |
Saba NF, Rossi MR, Dwivedi B, Switchenko JM, Magliocca KR, Ramalingam SS, Owonikoko TK, Khuri FR, Chen ZG, Kowalski J, Shin DM. Predictive value of gene expression signatures in premalignant lesions of the head and neck for response to chemoprevention with EGFR and COX-2 inhibitors. Journal of Clinical Oncology. 32: e17053-e17053. DOI: 10.1200/Jco.2014.32.15_Suppl.E17053 |
0.328 |
|
| 2014 |
Lutterman AC, Switchenko JM, Pan T, Read WL. Utilizing nomogram-predicted outcomes as the control group in randomized clinical trials. Journal of Clinical Oncology. 32: 6592-6592. DOI: 10.1200/Jco.2014.32.15_Suppl.6592 |
0.306 |
|
| 2014 |
Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Langston A, Pentz R, Waller EK. Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation Blood. 124: 6002-6002. DOI: 10.1182/Blood.V124.21.6002.6002 |
0.359 |
|
| 2014 |
Ramachandiran S, Koff JL, Garderet L, Saxe D, Ikhlef S, Kelkar N, Kaplan L, El-Cheikh J, Switchenko JM, Sunay S, Khoury HJ, Kaufman JL, Lonial S, Boise LH, Kowalski J, et al. Detection of NFKB2 3’end Loos By Quantitative PCR (QPCR) or Detection of NFKB2 Rearrangements Correlate with Bortezomib Response in Multiple Myeloma Blood. 124: 2138-2138. DOI: 10.1182/Blood.V124.21.2138.2138 |
0.349 |
|
| 2014 |
Owonikoko TK, Zhang G, Sica GL, Chen Z, Switchenko JM, Kim S, Gal AA, Ramalingam SS, Deng X, Rossi MR, Kowalski J, Khuri FR. Abstract 922: Evaluating markers of cisplatin sensitivity and survival in small cell lung cancer Cancer Research. 74: 922-922. DOI: 10.1158/1538-7445.Am2014-922 |
0.353 |
|
| 2014 |
Lim T, Prabhu R, Switchenko J, Mister D, Torres M. Skin Sparing Mastectomy and Immediate Reconstruction in Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy and Postmastectomy Radiation Therapy: Long-Term Oncologic and Patient-Reported Quality of Life Outcomes International Journal of Radiation Oncology*Biology*Physics. 90: S171. DOI: 10.1016/J.Ijrobp.2014.05.677 |
0.389 |
|
| 2014 |
Kandula S, Switchenko J, Fasola C, Mister D, Torres M. The Influence of Receptor Status on Locoregional Recurrence Risk Among Breast Cancer Patients With Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Mastectomy International Journal of Radiation Oncology*Biology*Physics. 90: S70. DOI: 10.1016/J.Ijrobp.2014.05.231 |
0.334 |
|
| 2014 |
Colbert L, Hall W, Mosley C, Seldon C, Mittal P, Switchenko J, Mikell J, Mavraj G, Yu D, Landry J, Curran W. The Use of MRI for GTV Delineation in Borderline and Locally Advanced Pancreatic Cancer Increases Local Control in Patients Treated With Intensity Modulated Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 90: S354-S355. DOI: 10.1016/J.Ijrobp.2014.05.1152 |
0.359 |
|
| 2013 |
Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB. Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate. Practical Radiation Oncology. 3: e157-64. PMID 24674413 DOI: 10.1016/J.Prro.2013.01.003 |
0.363 |
|
| 2013 |
Marcus DM, Switchenko JM, Prabhu R, O'Regan R, Zelnak A, Fasola C, Mister D, Torres MA. Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer. Frontiers in Oncology. 3: 317. PMID 24409418 DOI: 10.3389/Fonc.2013.00317 |
0.393 |
|
| 2013 |
Bulka C, Nastoupil LJ, McClellan W, Ambinder A, Phillips A, Ward K, Bayakly AR, Switchenko JM, Waller L, Flowers CR. Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer. 119: 3309-17. PMID 23896932 DOI: 10.1002/Cncr.28083 |
0.499 |
|
| 2013 |
Wood WC, Switchenko JM. Patent foramen ovale and cryptogenic stroke. The New England Journal of Medicine. 369: 88. PMID 23822783 DOI: 10.1056/Nejmc1305429#Sa1 |
0.305 |
|
| 2013 |
Colbert LE, Hall WA, Nickleach D, Liu Y, Switchenko JM, Gillespie TW, Lipscomb J, Kooby DA, Kauh JS, Landry JC. Radiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base: A multi-institutional comparative analysis. Journal of Clinical Oncology. 31: 305-305. DOI: 10.1200/Jco.2013.31.4_Suppl.305 |
0.424 |
|
| 2013 |
Bulka C, Nastoupil LJ, Koff J, Bernal L, Ward K, Bayakly R, Switchenko J, Waller L, Flowers CR. Relationship Between Residential Proximity To Environmental Protection Agency (EPA) Designated Toxic Release Sites and The Risk Of Diffuse Large B-Cell Lymphoma (DLBCL) Blood. 122: 1684-1684. DOI: 10.1182/Blood.V122.21.1684.1684 |
0.517 |
|
| 2013 |
Bulka C, Nastoupil LJ, Switchenko J, Ward K, Bayakly R, Waller L, Flowers CR. Spatial Epidemiology Of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma In The State Of Georgia Blood. 122: 1683-1683. DOI: 10.1182/Blood.V122.21.1683.1683 |
0.517 |
|
| 2013 |
Mikell J, Waller E, Rangaraju S, Switchenko J, Ali Z, Graiser M, Hall W, Langston A, Esiashvili N, Khan M. Similar Survival for Patients Undergoing Reduced-Intensity TBI Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leukemia International Journal of Radiation Oncology*Biology*Physics. 87: S558. DOI: 10.1016/J.Ijrobp.2013.06.1478 |
0.331 |
|
| 2012 |
Ali A, Switchenko J, Kim S, Kowalski J, Higgins K, Beitler J. A SEER-based Probability Model Using HPV Status and Lymph Node Levels to Predict Primary Head-and-Neck Tumor Site for Squamous Cell Cancer Confined to Cervical Lymph Nodes International Journal of Radiation Oncology*Biology*Physics. 84: S508. DOI: 10.1016/J.Ijrobp.2012.07.1354 |
0.316 |
|
| Show low-probability matches. |